UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Autologous stem cell transplantation is safe and effective for fit older myeloma patients: exploratory results from the Myeloma XI trial

Haematologica (Roma), 2022-01, Vol.107 (1), p.231-242

2022

Volltextzugriff (PDF)

A comparison of various aggregation functions in multi-criteria decision analysis for drug benefit–risk assessment

Statistical methods in medical research, 2022-05, Vol.31 (5), p.899-916

2022

Volltextzugriff (PDF)

Minimal Residual Disease After Autologous Stem-Cell Transplant for Patients With Myeloma: Prognostic Significance and the Impact of Lenalidomide Maintenance and Molecular Risk

Journal of clinical oncology, 2022-09, Vol.40 (25), p.2889-2900

2022

Volltextzugriff (PDF)

The Impact of Lymphocyte Composition in the Stem Cell Harvest on Blood Lymphocytes 1-2 Weeks Post-Autologous Stem Cell Transplant for Newly Diagnosed Myeloma

Blood, 2022-11, Vol.140 (Supplement 1), p.4299-4300

2022

Volltextzugriff (PDF)

Second Primary Malignancy Incidence in Patients Receiving Lenalidomide at Induction and Maintenance; Long-Term Follow up of 4358 Patients Enrolled to the Myeloma XI Trial

Blood, 2022-11, Vol.140 (Supplement 1), p.1823-1825

2022

Volltextzugriff (PDF)

Defining the Optimal Duration of Lenalidomide Maintenance after Autologous Stem Cell Transplant - Data from the Myeloma XI Trial

Blood, 2022-11, Vol.140 (Supplement 1), p.1371-1372

2022

Volltextzugriff (PDF)

Phenotypic High-Risk Disease in the Context of Carfilzomib and Lenalidomide Combination Induction Therapy for Newly Diagnosed Transplant-Eligible Myeloma Patients

Blood, 2021-11, Vol.138 (Supplement 1), p.2907-2907

2021

Volltextzugriff (PDF)

Residual Monoclonal Free Light Chain Positivity By Mass Spectrometry Identifies Patients at Increased Risk of Early Relapse Following First-Line Anti-Myeloma Treatment

Blood, 2021-11, Vol.138 (Supplement 1), p.820-820

2021

Volltextzugriff (PDF)

The Impact of Autologous Stem Cell Transplantation on the Genetics of High-Risk Relapsed Multiple Myeloma

Blood, 2022-11, Vol.140 (Supplement 1), p.4232-4233

2022

Volltextzugriff (PDF)

The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from ‘Myeloma XI’, a multicentre, open‐label, randomised, phase III trial

British journal of haematology, 2023-04, Vol.201 (2), p.267-279

2023

Volltextzugriff (PDF)

Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI Trial

Clinical lymphoma, myeloma and leukemia, 2021-10, Vol.21 (10), p.667-675

2021

Volltextzugriff (PDF)

The Addition of Carfilzomib to a Lenalidomide-Based Triplet Improves Outcomes in Newly Diagnosed Transplant Eligible Myeloma Patients with Renal Impairment: A Subgroup Analysis of the Myeloma XI Trial

Blood, 2020-11, Vol.136 (Supplement 1), p.40-43

2020

Volltextzugriff (PDF)

Impact of Etiological Cytogenetic Abnormalities on Immunoparesis and Progression-Free and Overall Survival in Newly Diagnosed Multiple Myeloma

Blood, 2020-11, Vol.136 (Supplement 1), p.6-6

2020

Volltextzugriff (PDF)

OAB-015: Minimal residual disease following autologous stem cell transplant for myeloma patients in the Myeloma XI trial: prognostic significance and the impact of lenalidomide maintenance and molecular risk

Clinical lymphoma, myeloma and leukemia, 2021-10, Vol.21, p.S10-S10

2021

Volltextzugriff (PDF)

Impact of Etiological Cytogenetic Abnormalities on the Depth of Immunoparesis and Survival in Newly Diagnosed Multiple Myeloma

Clinical lymphoma, myeloma and leukemia, 2022-04, Vol.22 (4), p.e279-e284

2022

Volltextzugriff (PDF)

Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI TrialResearch in context

EClinicalMedicine, 2023-08, Vol.62, p.102099

2023

Volltextzugriff (PDF)

Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI Trial

EClinicalMedicine, 2023-08, Vol.62, p.102099-102099, Article 102099

2023

Volltextzugriff (PDF)

Clinical characteristics and outcomes of IgD myeloma: experience across UK national trials

Blood advances, 2022-09, Vol.6 (17), p.5113-5123

2022

Volltextzugriff (PDF)

A microRNA that controls the emergence of embryonic movement

eLife, 2024-06, Vol.13

2024

Volltextzugriff (PDF)

A Bayesian analysis of a Test and Vaccinate or Remove study to control bovine tuberculosis in badgers (Meles meles)

PloS one, 2021-01, Vol.16 (1), p.e0246141-e0246141

2021

Volltextzugriff (PDF)

Virulence phenotypes of Puccinia graminis on barley, wheat and oat in Canada from 2020 to 2022

Canadian journal of plant pathology, 2024-05, p.1-7

2024

Volltextzugriff (PDF)

Changes in hot spring temperature and hydrogeology of the Alpine Fault hanging wall, New Zealand, induced by distal South Island earthquakes

Geofluids, 2015-02, Vol.15 (1-2), p.216-239

2015

Volltextzugriff (PDF)

Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study

The Lancet global health, 2017-11, Vol.5 (11), p.e1123-e1132

2017

Volltextzugriff (PDF)

Modelling the health and economic impacts ofM72/AS01E vaccination and BCG-revaccination: Estimates for South Africa

Vaccine, 2024-02, Vol.42 (6), p.1311-1318

2024

Volltextzugriff (PDF)

Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study

American journal of respiratory and critical care medicine, 2021-04, Vol.203 (7), p.871-881

2021

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(77)

Publikationsform

Sprache

Englisch
(85)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(58)
Life Sciences & Biomedicine
(51)
Humans
(34)
Female
(18)
Male
(17)
Middle Aged
(17)
Adult
(16)
Aged
(11)
Infectious Diseases
(9)
Young Adult
(9)
Adolescent
(8)
Aged, 80 And Over
(7)
Australia - Epidemiology
(7)
Biological And Medical Sciences
(7)
Child
(7)
Immunology
(7)
Infant
(7)
Infant, Newborn
(7)
Pneumococcal Infections - Epidemiology
(7)
Child, Preschool
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Autologous stem cell transplantation is safe and effective for fit older myeloma patients: exploratory results from the Myeloma XI trial

A comparison of various aggregation functions in multi-criteria decision analysis for drug benefit–risk assessment

Minimal Residual Disease After Autologous Stem-Cell Transplant for Patients With Myeloma: Prognostic Significance and the Impact of Lenalidomide Maintenance and Molecular Risk

The Impact of Lymphocyte Composition in the Stem Cell Harvest on Blood Lymphocytes 1-2 Weeks Post-Autologous Stem Cell Transplant for Newly Diagnosed Myeloma

Second Primary Malignancy Incidence in Patients Receiving Lenalidomide at Induction and Maintenance; Long-Term Follow up of 4358 Patients Enrolled to the Myeloma XI Trial

Defining the Optimal Duration of Lenalidomide Maintenance after Autologous Stem Cell Transplant - Data from the Myeloma XI Trial

Phenotypic High-Risk Disease in the Context of Carfilzomib and Lenalidomide Combination Induction Therapy for Newly Diagnosed Transplant-Eligible Myeloma Patients

Residual Monoclonal Free Light Chain Positivity By Mass Spectrometry Identifies Patients at Increased Risk of Early Relapse Following First-Line Anti-Myeloma Treatment

The Impact of Autologous Stem Cell Transplantation on the Genetics of High-Risk Relapsed Multiple Myeloma

The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from ‘Myeloma XI’, a multicentre, open‐label, randomised, phase III trial

Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI Trial

The Addition of Carfilzomib to a Lenalidomide-Based Triplet Improves Outcomes in Newly Diagnosed Transplant Eligible Myeloma Patients with Renal Impairment: A Subgroup Analysis of the Myeloma XI Trial

Impact of Etiological Cytogenetic Abnormalities on Immunoparesis and Progression-Free and Overall Survival in Newly Diagnosed Multiple Myeloma

OAB-015: Minimal residual disease following autologous stem cell transplant for myeloma patients in the Myeloma XI trial: prognostic significance and the impact of lenalidomide maintenance and molecular risk

Impact of Etiological Cytogenetic Abnormalities on the Depth of Immunoparesis and Survival in Newly Diagnosed Multiple Myeloma

Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI TrialResearch in context

Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI Trial

Clinical characteristics and outcomes of IgD myeloma: experience across UK national trials

A microRNA that controls the emergence of embryonic movement

A Bayesian analysis of a Test and Vaccinate or Remove study to control bovine tuberculosis in badgers (Meles meles)

Virulence phenotypes of Puccinia graminis on barley, wheat and oat in Canada from 2020 to 2022

Changes in hot spring temperature and hydrogeology of the Alpine Fault hanging wall, New Zealand, induced by distal South Island earthquakes

Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study

Modelling the health and economic impacts ofM72/AS01E vaccination and BCG-revaccination: Estimates for South Africa

Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study

Suchergebnisse filtern